Clinical trial
The Effect of Intravenous Magnesium Sulfate Use on Intraoperative Remifentanil Consumption and Postoperative Pain in Abdominal Hysterectomy Cases
NCT05644873 is registered in ClinicalTrials.gov with Ondokuz Mayıs University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Intravenous Magnesium Sulfate Use on Intraoperative Remifentanil Consumption and Postoperative Pain in Abdominal Hysterectomy Cases
- Lead sponsor
- Ondokuz Mayıs University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 15, 2023
- Completion date
- April 30, 2024
- Enrollment
- 48 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
abdominal hysterectomy, general anesthesia, magnesium sulfate